Janux Therapeutics, Inc.
JANXBiotechnology
$17.83−1.22%As of Oct 29vs prior close
- Market cap
- $1.1B
- P/E (TTM)
- –
- From 52W high
- −48.68%
- EPS (LTM)
- -$1.64
- Revenue (LTM)
- $24M
- Net margin
- -427.47%
- Dividend yield
- 0.00%
Nomior Score
34
Steady ProfileBottom 20% of the scored universe
Growth47
Quality47
Value57
Momentum20
Resilience37
Growth
$24Mrevenue, LTM
YE20 $0LTM $24M
Connections
Revenue to profitQ2 YE26
The operating loss was 309% of revenue.
Who owns it
2funds